Importantly, the expression of regulatory T cell molecules CD39 and CD73 on γδ T cells and Trm, including CD4 Trm in LPL, was reduced in CRC patients, strengthening the inference that immune barrier function and homeostasis are compromised in those developing CRC. This evidence concerns the gene CD4 and colorectal carcinoma.